Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.474
-0.032 (-2.12%)
Oct 13, 2026, 12:38 PM CET
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 919.83 million as of October 12, 2026. It is the 25,831st most valuable company in the world and the 319th biggest in Sweden. Its market cap has increased by 1,177.33% in one year.
Market Cap
919.83M
Enterprise Value
670.83M
Revenue
8.71M
Global Rank
Country Rank
#319 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 30, 1999, Medivir AB's market cap has increased from 643.11M to 919.83M, an increase of 43.03%. That is a compound annual growth rate of 1.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 919.83M | 401.25% |
| Dec 30, 2025 | 183.51M | -42.39% |
| Dec 30, 2024 | 318.56M | 100.20% |
| Dec 29, 2023 | 159.12M | -71.16% |
| Dec 30, 2022 | 551.67M | -11.61% |
| Dec 30, 2021 | 624.11M | 209.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioInvent International AB | 1.53B |
| Genovis AB (publ.) | 1.37B |
| Saniona AB | 1.32B |
| Flerie AB | 1.32B |
| Oncopeptides AB | 1.17B |
| Infant Bacterial Therapeutics AB | 975.33M |
| SynAct Pharma AB | 946.37M |
| AlzeCure Pharma AB | 932.19M |